Manuscript Review CME
Continuing Medical Education (CME) Credit for Journal of Thoracic Oncology Manuscript
International Association for the Study of Lung Cancer (IASLC) offers AMA PRA Category 1 Credit™ for reviewing manuscripts.Only reviews received on time and judged as satisfactory by the editor’s team responsible for the particular manuscript will be eligible for CME credit.
Accreditation and Designation Statements:
IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
IASLC designates this Manuscript Review activity for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Manuscript Review CME offers the physician reviewer AMA PRA Category 1 Credit™ for this learning endeavor. If requested, the reviewer may be awarded 3 AMA PRA Category 1 Credit™ per review; a reviewer may claim credit for a maximum of five reviews per year (15 AMA PRA Category 1 Credit™). Please submit ONLY one request per manuscript review.
Learning Objectives: The process of reviewing manuscripts for publication requires specific skills and knowledge, both as a reviewer and in the content area of the manuscript itself. Engaging in the review process may require the physician reviewer to learn new skills or fortify existing expertise in order to complete the review process effectively. By participating in this Manuscript Review CME activity, the learner will be able to:
Evaluate how a research question or investigational clinical application is formulated and articulated in a proposed manuscript.
Improve their skill in the critical analysis of medical literature and knowledge of current issues in the field of thoracic oncology.
Increase their skill in reviewing and authoring journal articles, as well as improve behavior and performance in practice.
Conduct an appropriate review of the literature related to the proposed manuscript.
Synthesize the literature review with a thorough review of the proposed manuscript thereby identifying its strengths and weaknesses prior to publication.
Disclosure Information: The editors, authors, planners, reviewers, et.al. who were in a position to control and influence the content of this activity were required to disclose to IASLC Department of Education, any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content.
Journal of Thoracic Oncology (JTO) staff, authors, reviewers, editors, and planners associated with the development of content for this activity reported no relevant financial relationships. Final decisions regarding manuscript publication and CME content are made by an editor who does not have any relevant relationships with a commercial interest; thus, the editor has nothing to disclose.
If the CME article describes a) the use of a device, product or drug that is not FDA approved, or b) an off label use of an approved device, product, or drug, this information will be disclosed in the introduction of the CME activity.
Resolution of Conflicts of Interest: In accordance with the ACCME Standards for Commercial Support of CME, IASLC has implemented mechanisms, prior to the planning and implementation of this Manuscript Review CME activity, to identify and resolve conflicts of interest for all individuals in a position to control the content of this Manuscript Review activity. All COI was resolved prior to the Manuscript Review activity. If any reviewer has a conflict of interest related to the article in review, he/she will be prohibited from reviewing the article.
Process for Claiming Credit: Only reviews received on time and judged as satisfactory by the editor (Editor-in-Chief or Associate/Senior Editors) responsible for the particular manuscript will be eligible for CME credit. The features that contribute most importantly to the quality of manuscript reviews for the IASLC: adherence to reviewer guidelines, specificity and accuracy, completeness, usefulness of recommendations to editors and authors, tone, internal consistency, and understanding of the needs of the journal'sreaders. The reviewer should place the current work in the context of existing evidence in the area, describe the unique contributions of the current work, and comment on any inconsistencies of the current work with previous research in the area as well as any methodological or experimental issues. The chosen article reviewers will be emailed a CME Request Form for Manuscript Review in order to receive credit. The CME certificate will be ready for them to print or save upon completion.
Disclaimer: IASLC is not responsible for statements made by the author(s). Statements or opinions expressed in this activity reflect the views of the author(s) and do not reflect the official policy of the International Association for the Study of Lung Cancer. The information provided in this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to the diagnostic, management, and treatment options of a specific patient’s medical condition.
Provider Contact Information: Questions regarding this online CME activity should be directed to IASLC Department of Continuing Medical Education at 13100 East Colfax Avenue, Unit # 10, Aurora, CO 80011; 720-598-1945, firstname.lastname@example.org
Copyright Notice: All CME articles published in the Journal of Thoracic Oncology (JTO) and attendant CME activities are copyrighted by the International Association for the Study of Lung Cancer.
Commercial Supporter information: There is no commercial support for Internet Journal or Manuscript Review CME activities.
Thank you for your participation.